Florian Groeber‐Becker

Düsseldorf University Hospital

Papers

1

Total Citations

13

H-Index

1

About

Florian Groeber‐Becker is a pioneering researcher at the intersection of biomedical engineering and automation, with a primary focus on developing animal-free, human-relevant tissue models for drug testing and toxicology. His most notable contribution is the development of ReBiA—Robotic Enabled Biological Automation, a groundbreaking platform for the automated production of 3D epithelial tissues. This work, published in 2024 and already garnering 13 citations, directly addresses the global shift away from animal testing, aligning with recent FDA policy changes and European Parliament initiatives. Groeber‐Becker’s research streamlines the complex, labor-intensive process of tissue engineering, making it scalable and reproducible for high-throughput screening. By integrating robotics with cell biology, he enables the consistent fabrication of human skin and other epithelial models, which are critical for pharmaceutical safety assessments and personalized medicine. His contributions are particularly timely as regulatory bodies worldwide move toward animal-free research practices. With a citation count reflecting the immediate relevance of his work, Groeber‐Becker is positioned at the forefront of the transition to ethical, human-relevant biomedical research, offering practical solutions that bridge the gap between laboratory innovation and industrial application.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
ReBiA—Robotic Enabled Biological Automation: 3D Epithelial Tissue Production
13 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Düsseldorf University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago